ALPHA-HELICAL CRF (9-41)
- CAS No.
- 99658-03-4
- Chemical Name:
- ALPHA-HELICAL CRF (9-41)
- Synonyms
- ALPHA-HELICAL CRF (9-41);CORTICOTROPIN RELEASING FACTOR ANTAGONIST;α-Helical CRF (9-41) trifluoroacetate salt;ALPHA-HELICAL CORTICOTROPIN RELEASING FA CTOR;Alpha-Helical CRF (9-41) trifluoroacetate salt;ALPHA-CORTICOTROPIN-RELEASING FACTOR 9-41, HELICAL;ALPHA-HELICAL CORTICOTROPIN RELEASING FACTOR (9-41);alpha-Helical corticotropin releasing factor fragment;α-helical corticotropin releasing factor fragment (9-41);ALPHA-HELICAL CORTICOTROPIN RELEASING FACTOR FRAGMENT (9-41)
- CBNumber:
- CB1103870
- Molecular Formula:
- C22H25IN2O6
- Molecular Weight:
- 540.34817
- MDL Number:
- MFCD00081543
- MOL File:
- 99658-03-4.mol
Product description | Number | Pack Size | Price |
Corticotropin Releasing Factor Antagonist ≥97% (HPLC) | C2917 | 0.1mg | $160 |
alpha-helicalCRF9-41 | 1184 | 500U | $306 |
Alpha-Helical CRF (9-41) > 95% | orb364215 | 1mg | $669.8 |
Alpha-Helical CRF (9-41) > 95% | orb364215 | 5mg | $1657.5 |
Alpha-Helical CRF (9-41) > 95% | orb364215 | 10mg | $2480.3 |
ALPHA-HELICAL CRF (9-41) price More Price(5)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich | C2917 | Corticotropin Releasing Factor Antagonist ≥97% (HPLC) | 99658-03-4 | 0.1mg | $160 | 2025-07-31 | Buy |
Tocris | 1184 | alpha-helicalCRF9-41 | 99658-03-4 | 500U | $306 | 2021-12-16 | Buy |
Biorbyt Ltd | orb364215 | Alpha-Helical CRF (9-41) > 95% | 99658-03-4 | 1mg | $669.8 | 2021-12-16 | Buy |
Biorbyt Ltd | orb364215 | Alpha-Helical CRF (9-41) > 95% | 99658-03-4 | 5mg | $1657.5 | 2021-12-16 | Buy |
Biorbyt Ltd | orb364215 | Alpha-Helical CRF (9-41) > 95% | 99658-03-4 | 10mg | $2480.3 | 2021-12-16 | Buy |
ALPHA-HELICAL CRF (9-41) Chemical Properties,Uses,Production
Uses
α-Helical Corticotropin Releasing Factor (9-41) is a corticotropin releasing factor (CRF) antagonist. α-Helical Corticotropin Releasing Factor (9-41) decreases plasma growth hormone (GH) values in vivo[1][2].
Biochem/physiol Actions
The corticotropin releasing factor (CRF) antagonist α-helical CRF [9-41] exhibits 10-fold higher affinity for rat CRF2α receptors over human CRF2α receptors. It has been used to elucidate the role of CRF in various physiological systems. In colonic epithelium, it abolishes CRF-induced changes in ion secretion, and significantly inhibits CRF-stimulated conductance. It antagonizes the CRF-induced proinflammatory degranulation of perivascular mast cells that are activated in response to acute psychological stress and CRF secretion.
in vivo
α-Helical Corticotropin Releasing Factor (9-41) (10 μg; the third or lateral ventricle of the brain injection; once) significantly decreases plasma GH values[1]. α-Helical Corticotropin Releasing Factor (9-41) (100 ng/kg; i.c.v. once) affects rhlL-1/β-induced enhancement of the splenic sympathetic activity[2].
Animal Model: | Adult Sprague-Dawley rats[1] |
Dosage: | 10 μg |
Administration: | The third or lateral ventricle of the brain injection; 10 μg once |
Result: | Abolished the 10 min electroshocks-produced the decreasing of plasma GH levels by injected into the third or lateral ventricle of the brain 45 min before exposure to stress. |
Animal Model: | Adult Sprague-Dawley rats with immunity of endogenous somatostatin (SS)[1] |
Dosage: | 10 μg |
Administration: | Lateral ventricle brain injection; 10 μg once |
Result: | Showed no effect on plasma GH values in rats whose endogenous SS had been immunoneutralized, but did interfere with the stimulatory effect of GH-releasing factor (GRF). |
Animal Model: | Male Wistar rats with rhlL-1/β injection[2] |
Dosage: | 100 ng/kg |
Administration: | Intracerebroventricularly injection; 100 ng/kg once |
Result: | Completely blocked the rhlL-1/β-induced enhancement of the splenic sympathetic activity, but failed to alter the enhancement of nociceptive behaviors caused by rhlL-1/β. |
References
[1] Rivier C, Vale W. Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology. 1985 Dec;117(6):2478-82. DOI:10.1210/endo-117-6-2478
[2] Takakazu Oka, et al. Intracerebroventricular injection of interleukin-1/β induces hyperalgesia in rats. Brain Research, 624 (1993) 61-68.
ALPHA-HELICAL CRF (9-41) Preparation Products And Raw materials
Raw materials
Preparation Products
ALPHA-HELICAL CRF (9-41) Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Cellmano Biotech Limited | 0551-65326643 18156095617 | info@cellmano.com | China | 995 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | laboratory@coreychem.com | China | 30229 | 58 |
Chengdu Youngshe Chemical Co., Ltd. | +8618108235634 | Cecilia@youngshechem.com | China | 2345 | 58 |
Nanjing TGpeptide | +86-13347807150 | support@tgpeptide.com | China | 3279 | 58 |
3B Pharmachem (Wuhan) International Co.,Ltd. | 821-50328103-801 18930552037 | 3bsc@sina.com | China | 15839 | 69 |
Shanghai Hanhong Scientific Co.,Ltd. | 021-54306202 13764082696 | info@hanhongsci.com | China | 42943 | 64 |
Chemsky(shanghai)International Co.,Ltd. | 021-50135380 | shchemsky@sina.com | China | 32321 | 50 |
Hunan Hui Bai Shi Biotechnology Co., Ltd. | 0731-85526065 13308475853 | ivy@hnhbsj.com | China | 7247 | 62 |
Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 | sales@reading-chemicals.com | China | 15178 | 58 |
Sigma-Aldrich | 021-61415566 800-8193336 | orderCN@merckgroup.com | China | 51395 | 80 |
99658-03-4(ALPHA-HELICAL CRF (9-41))Related Search:
1of4